Targeting polo‐like kinase 1, a regulator of p53, in the treatment of adrenocortical carcinoma

Overview of attention for article published in Clinical and Translational Medicine, January 2016

Altmetric Badge

About this Attention Score

Average Attention Score compared to outputs of the same age
Above-average Attention Score compared to outputs of the same age and source (62nd percentile)

Mentioned by

twitter: 3 X users

Citations

dimensions_citation: 24 Dimensions

Readers on

mendeley: 18 Mendeley

Summary X Dimensions citations

So far, Dimensions has found 24 publications that cite this research output.

24

The most recent citing publications are shown below. View all 24 publications that cite this research output on Dimensions.

Identification of Key Genes and Related Drugs of Adrenocortical Carcinoma by Integrated Bioinformatics Analysis

Article in Hormone and Metabolic Research (December 2023)

PLK1 inhibitors as a new targeted treatment for adrenocortical carcinoma

Article in Endocrine Connections (December 2023)

Advances in translational research of the rare cancer type adrenocortical carcinoma

Article in Nature Reviews Cancer (October 2023)